Blood pressure self-measurement is increasing in most communities and yet its role in the management of hypertension is poorly understood. This study was devised to evaluate the behaviour of doctors in general practice when treating patients with poorly controlled essential hypertension who use self-measurement. Patients, most of whom were already taking antihypertensive medications were commenced on perindopril or indapamide at their doctor's discretion and were randomly allocated to self-measurement (SM) using an OMRON HEM706 oscillometric device or a continuation of their usual care (UC) over an 8-week period. This was an observational study without any specific or set treatment goals for the doctor to follow. Sixty of 62 subjects completed the study and the two groups were equally matched for age, body mass index, gender, and blood pressure (BP). While additional perindopril or indapamide produced a significant fall in BP in both groups over the study period, the systolic pressure remained significantly higher in the SM group (sitting 148 ± 3 compared with 142 ± 3; 145 ± 3 compared with 138 ± 3
Introduction
Self (home)-blood pressure (BP) management use in our patients is rapidly increasing. This largely patient-driven development has been facilitated by the ready availability of reliable, affordable and easy-to-use automatic oscillometric devices. While reliable figures of ownership and use do not exist, 70% of people who recently phoned a German Cardiovascular Hotline practised self-measurement although only one-third did so on the advice or prescription of their physician. 1 In the USA, the total cost for these devices was estimated at $126 million during 1994 2 and sales are increasing in many countries. Despite accumulating evidence that selfmeasurement produces comparable clinical information to physician prescribed ambulatory BP monitoring (ABPM), little patient outcome data has mm Hg respectively; P Ͻ 0.05). Twenty-four hour and daytime ambulatory monitor systolic pressures were also significantly higher in the SM group. Differences in diastolic BP were not statistically significant. Furthermore, SM patients were less likely to have their medications increased and more likely to have them reduced or ceased. Doctors and patients found self-measurement convenient and useful. This study suggests that doctors prescribing decisions are influenced by evidence from self-measurement of BP with consequential increases in office BP related to reduced drug use. While self-BP measurement can offer reassurance about adequacy of control when away from a physicians office, our best evidence of understanding target blood pressures comes from large randomised studies using office blood pressures as an end-point. There is an urgent need for further study to provide arbitration between self-measurement and office blood pressures although each measurement must contribute to the management of hypertension. accumulated with self-measurement. [2] [3] [4] Guidelines for self-measurements are being developed but have not yet achieved the clinical rigour of conventional measurements. 2 With the popularity of selfmeasurement combined with anecdotal information that patients frequently present to their doctor with self-measurement diaries, it is not yet known how doctors should or do utilize this additional information. Studies that compared self and also ABP monitoring with conventional or usual care have not addressed this important question 5, 6 since participating doctors were asked to follow a specific protocol during the management of their patients. Consequently, our study was devised to evaluate the behaviour of general practitioners who were faced with their own office pressures as well as multiple self-measurements when treating patients with antihypertensive medications. A usual care group was also studied.
Subjects and methods
Eight general practitioners in the Newcastle area (Australia) were randomly selected from a group of 62 doctors who have participated in our clinical research programmes. They were requested to identify adult male and female patients with uncomplicated essential hypertension who did not practice self-measurement. All patients approached were about to be commenced on an angiotensinconverting enzyme (ACE) inhibitor (perindopril) or a diuretic (indapamide). These medications could be an addition to current medications due to inadequate control or primary treatment in those about to commence active drug therapy. This study was not designed to specifically evaluate the antihypertensive effects of these agents and they were chosen to minimise the number of drugs used. Patients who were unable to use a self-measurement device due to dementia, acute psychiatric syndrome, or arthritis were excluded. Informed consent was obtained and the study was approved by the University of Newcastle Human Research Ethics Committee.
Study protocol
Prior to commencing the new antihypertensive drug, all selected subjects were visited by a research nurse (BB) who measured their weight, height, arm circumference, pulse and sitting (10 min) and standing (5 min) BP with a mercury sphygmonometer. Subjects randomly allocated to monitor their own BP during the 8-week study period were instructed in the use of an OMRON HEM706 monitor and asked to record their sitting BP twice daily (immediately before morning BP medications, and between 6 and 8 pm). Usual care (UC) patients did not take their own blood pressure at home. At study completion, all patients were reviewed by the same trial nurse and their pulse and BP were again measured and their medication dose and compliance checked, the latter by tablet count. Twenty-four hour ABPM was also completed in all patients (Spacelabs 90207: Redmond, WA, USA). Self-measurement patients were also asked to complete a four-part questionnaire regarding their satisfaction with the selfmeasurement process. Their doctors completed a similar questionnaire. When the study had been completed but before data analysis, doctors were asked to complete another four-part questionnaire to evaluate their perceptions of how self-measurement influenced their use of antihypertensive drugs.
Data analysis
A Student's t-test was used to analyse differences between groups in pulse rate and BP and a paired ttest was used for within group changes. Proportions were compared using the 2 statistic. Results are expressed as means ± s.e.m., and P Ͻ 0.05 was considered statistically significant.
Results
Sixty of 62 subjects who agreed to enter completed the study. One subject in the self-measurement (SM) group could not tolerate ABPM at study completion and one subject in the UC group developed nausea which was attributed to indapamide and did not complete the study. The characteristics of the two randomised patient groups appeared to be comparable in age, body mass index, gender and length of hypertension treatment (Table 1) . Two patients in each group had not previously taken antihypertensive medications. ACEinhibitors were used in six SM and five UC, calcium antagonists in four SM and three UC, beta-blockers in two SM and two UC, and diuretics in two SM and two UC patients. Additional perindopril or indapamide was used in 14 SM and 12 UC patients while in 15 SM and UC patients, perindopril or indapamide replaced other medications. Mean systolic and diastolic BP (sitting and standing) prior to study commencement were also comparable ( Table 2) .
The initiation and dosage regime of perindopril or indapamide which was at the discretion of the treating doctor produced a significant fall in systolic and diastolic BP in both groups at the end of the 8-week period. However, the falls were significantly greater in the UC group with a 13 mm Hg fall in systolic Table 2 Baseline and follow-up blood pressure after 8 weeks in usual care and self-measurement groups
Usual care
Selfmeasurement
Study commencement
Sitting BP (mm Hg) 155 ± 4 156 ± 4 95 ± 2 9 3 ± 2 Sitting pulse (bpm) 77 ± 2 7 8 ± 3 Standing BP (mm Hg) 151 ± 4 152 ± 4 94 ± 2 9 3 ± 2 Standing pulse (bpm) 81 ± 3 8 2 ± 3
Study completion
Sitting BP (mm Hg) 142 ± 3 148 ± 3* 89 ± 2 8 9 ± 2 Sitting pulse (bpm) 76 ± 3 7 6 ± 2 Standing BP (mm Hg) 138 ± 3 145 ± 3* 87 ± 2 8 9 ± 2 Standing pulse (bpm) 79 ± 3 8 0 ± 2 24 h mean ABPM (mm Hg) 130 ± 3 137 ± 3* 78 ± 2 7 9 ± 2 Daytime mean ABPM (mm Hg) 133 ± 3 141 ± 3* 81 ± 2 8 3± 2
Mean ± s.e.m. *Significantly greater than usual care (P Ͻ 0.05). (Table 3) showed a significant fall in BP by the second week (P Ͻ 0.01) which was maximal at week 8. These readings were similar to those measured with daytime ABPM; pm blood pressures were lower than am pressures (P Ͻ 0.01). Twenty-four of 31 patients completed all twice-daily measurements over the 8-week period while the other seven patients completed at least 80% daily readings. Evaluation of medication compliance as judged by tablet counts did not demonstrate any difference between the UC and SM groups (Table 4) . Fourteen patients started perindopril at study commencement in both groups, the remainder started indapamide. The mean starting dose of perindopril was 2.6 mg/day in both groups while the mean dose at study completion was 3.3 mg/day in the UC group and 3.0 mg/day in the SM group. The perindopril dose was increased in five UC and four SM patients. The dose of other antihypertensive drugs was increased in three UC and one SM patient while additional medications were started during the 8-week period in three UC patients and one SM patient. A drug class was also stopped in two SM patients (Table 4) . Overall, medications were more likely to be unchanged or increased in UC compared with SM patients (P Ͻ 0.05). No differences in the frequency of doctor visits was observed between the two groups.
Analysis of the doctor and patient questionnaires in SM patients demonstrated that 94% of doctors and 100% of patients found self-measurement helpful or very helpful and 90% of doctors and 74% of patients felt that they would like to continue to use self-measurement. However, 23% of patients were disinterested. Both doctors and patients were aware of the disagreement between SM and office pressures with 19 and 16% respectively finding little agreement, although 42 and 45% found agreement most of the time. At study completion but before the doctors involved had seen the study results, they were asked four questions (Table 5 ). All agreed that during a consultation where self-measurement was significantly lower than office pressures, they were less likely to increase doses or add new drugs, more likely to be satisfied with BP control, and would not base treatment on office pressures alone. The doctors selected for this study were a representative sample of clinicians in the area in regards to age and ethnicity. Three of the eight doctors were female. This sample size was not large enough to detect a difference in doctor behaviour.
Discussion
Self-measured BP with current automatic devices is easy to perform, reliable, reproducible and in most studies such measurements are comparable to ABPM results. [2] [3] [4] 7 Furthermore the device used in this study has been validated according to accepted protocols. 8 Our study was devised to evaluate general practitioners' utilization of self-measurement information. Since self-measurements like ABPM measurements are often lower than office pressures, both in treated and untreated patients, an understanding of how doctors deal with potentially divergent clinical information is important. Rather than choose patients who were adequately controlled, subjects with poor control according to their doctor's criteria were chosen so that therapeutic decision making could be studied, a clinical scenario that has yet to be evaluated.
Staessen et al 6 compared conventional care with ABPM when, after a placebo period lisinopril was commenced. However, as stated in an editorial accompanying this study 'Since the same target BP was used in both groups, and office BP tends to be higher than ABP, patients in the ambulatory group would be expected to be prescribed less medication than the usual care group, and this is what was found'. 9 Systolic and to a lesser extent diastolic BP was also lower in the conventional treatment group due to additional drug treatment. Thus their results were similar to ours with increased medications and lower BP in the UC group. However, in contrast, doctors in our study were not directed to achieve a specific treatment goal. Physician's office pressures were not collected for analysis to minimise interference with prescribing patterns during the study period. Also, since patient visits did not follow any protocol and were dependent on physician-patient interaction, the sample size was unlikely to produce meaningful information. It is of interest to note that while the nurse-measured mean BP at study completion was higher than the patient measurements (148 ± 3/89 ± 2 compared with 140 ± 3/85 ± 2[am] and 136 ± 3/81 ± 2[pm] mm Hg, P Ͻ 0.01), the patient measurements were comparable to the daytime ABPM mean (141 ± 3/83 ± 3 mm Hg). These observations support published evidence that nurse and doctor blood pressures are similar particularly for systolic pressure, 10 as are self and ABPM measurements.
2-4
The doctor's questionnaire responses support the premise that their behaviour was influenced by selfmeasurement devices, even when this information did not agree with their own results. In another study where self-measurement was evaluated, the study protocol encouraged doctors to use mailed self-measurements instead of clinic visits. 5 Because of the marked reduction in clinic visits that resulted, further comparisons with our data cannot be made.
In summary, the results of our study are of concern, particularly since patients are increasingly presenting to their doctor with self-measurements. Doctors and their patients found self-measurement simple to perform and useful and there was general agreement that self-measurement had a significant role in the management of hypertension. While 23% of patients were disinterested in future self-measurement, they may have been better disposed to a less frequent monitoring program. Self-measurement was associated with higher nurse measured BP (systolic) and reduced medications. Although a series of satisfactory self-measurements might persuade a clinician not to increase BP medications despite relatively higher clinic pressures, the benefits of drug treatment in significantly lowering morbidity and mortality have as yet only been convincingly demonstrated during conventional office-based monitoring of BP. Patients often encourage their doctor not to increase medications if they are aware that their measurements are 'acceptable' despite an 'unacceptable' office pressure. This may lead to inadequate treatment since the recent results of the Hypertension Optimal Treatment (HOT) study 11 suggests that office-based pressures of 140/85 mm Hg offer maximal protection. However, increasing patient and doctor use and acceptance of self and ABPM measurements combined with possible evidence of reduced treatment costs [4] [5] [6] means that further rigorous evaluation of self-measurement is required.
